PhaseBio Pharmaceuticals (PHAS) Shareholding Patterns
$0.04
As on 04-Jan-2023 09:30EDT
Market cap
$4 Mln
Revenue (TTM)
$-10 Mln
P/E Ratio
--
P/B Ratio
26.2
Div. Yield
0 %
$0.04
As on 04-Jan-2023 09:30EDT
Market cap
$4 Mln
Revenue (TTM)
$-10 Mln
P/E Ratio
--
P/B Ratio
26.2
Div. Yield
0 %